Invention Grant
US08853355B2 Diagnosis and risk stratification by determining the marker CT-proADM
有权
通过确定标记CT-proADM进行诊断和危险分层
- Patent Title: Diagnosis and risk stratification by determining the marker CT-proADM
- Patent Title (中): 通过确定标记CT-proADM进行诊断和危险分层
-
Application No.: US13782027Application Date: 2013-03-01
-
Publication No.: US08853355B2Publication Date: 2014-10-07
- Inventor: Andreas Bergmann , Joachim Struck
- Applicant: BRAHMS GmbH
- Applicant Address: DE Hennigsdorf
- Assignee: B.R.A.H.M.S GmbH
- Current Assignee: B.R.A.H.M.S GmbH
- Current Assignee Address: DE Hennigsdorf
- Agency: Novak Druce Connolly Bove + Quigg LLP
- Priority: DE102006060112 20061220
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The invention relates to a novel diagnostic marker CT-proADM (C-terminal fragment of preproADM, SEQ ID No. 1) for diagnosing and/or stratifying the risk of diseases. Also disclosed is a method for diagnosing and/or stratifying the risk of diseases, particularly cardiovascular diseases, cardiac insufficiency, and infections and/or inflammations of the lungs and respiratory tract. In said method, the CT-proADM (SEQ ID No. 1) marker, or a partial peptide of fragment thereof, or said marker contained in a marker combination (panel, cluster) is determined in a patient who is to be examined. The invention further relates to a diagnostic apparatus as well as a kit for carrying out said method.
Public/Granted literature
- US20130266961A1 DIAGNOSIS AND RISK STRATIFICATION BY MEANS OF THE NOVEL MARKER CT-PROADM Public/Granted day:2013-10-10
Information query
IPC分类:
